Symptomatic treatment: irritation and inflammation of the oropharynx; pain caused by gingivitis, stomatitis, pharyngitis; in dentistry after tooth extraction or for preventive purposes.
Fari Verde Storage
active substance: benzydamine hydrochloride;
1 ml of oral spray contains 1.5 mg of benzydamine hydrochloride;
Excipients: saccharin, sodium bicarbonate, polysorbate 20, mint flavor, methylparaben (E 218), glycerin, ethanol 96%, purified water
Fari Verde Dosage form
Main physical and chemical properties: clear colorless liquid with a characteristic odor.
Fari Verde Pharmacotherapeutic group
Tools for use in dentistry. Other means for topical application in the oral cavity.
ATX code A01A D02.
Benzidamine hydrochloride is a non-steroidal anti-inflammatory drug that has analgesic and anti-inflammatory effects by stabilizing cell membranes and reducing prostaglandin synthesis.
Clinical studies of the original benzydamine have been shown to relieve symptoms of localized irritant pathological processes in the mouth and pharynx.
The drug has anti-inflammatory and local analgesic effects, has a local anesthetic effect on the mucous membrane of the oral cavity.
Benzidamine hydrochloride is absorbed through the mucous membranes of the mouth and pharynx. However, when using the drug in the form of an oral spray, the amount of benzydamine that enters the systemic circulation is insufficient to detect any systemic pharmacological effect. About half of the absorbed benzydamine is excreted by the kidneys, the rest is metabolized in the liver, mainly to N-oxide.
irritation and inflammation of the oropharynx;
pain caused by gingivitis, stomatitis, pharyngitis;
in dentistry after tooth extraction or for prophylactic purposes.
Hypersensitivity to the active substance or to other components of the drug.
Interaction with other medicinal products and other forms of interaction
Features of application
In cases of hypersensitivity with long-term use of the drug should discontinue its use and seek medical advice on the appointment of appropriate treatment.
In some patients, ulcers of the mucous membrane of the cheeks / pharynx can be caused by serious systemic pathological processes. Therefore, patients whose symptoms have worsened or not decreased within 3 days, or who have a fever or other symptoms, should consult a physician.
Benzidamine is not recommended in patients with hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs.
The drug can cause bronchospasm in patients with bronchial asthma or in patients with a history of bronchial asthma. Such patients must be warned.
For athletes: The use of drugs containing ethyl alcohol may give a positive result in the analysis of the anti-doping test, given the limits set by some sports federations.
The drug contains up to 10 vol. % ethanol (alcohol).
The drug contains methyl parahydroxybenzoate (methylparaben), which can cause allergic reactions (possibly delayed), and in some cases – bronchospasm.
Use during pregnancy or breastfeeding.
The drug should not be used during pregnancy or breastfeeding.
Ability to influence the speed of reaction when driving a car or other machinery.
When used in the recommended doses, the drug has no effect on the ability to drive and use machines.